Foundry Earnings Quality (Accruals) Industry-Neutral Factor ETF
ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Hypothetical growth of $1 — long-short backtest
Gross of the placeholder expense ratio and trading costs · not investor results
Holdings
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1NFLX | NETFLIX INC | Communication Services | $290.47B | 14.55% |
2GEV | GE VERNOVA INC | Utilities | $284.26B | 14.24% |
3BA | BOEING CO | Industrials | $168.72B | 8.45% |
4MO | ALTRIA GROUP INC | Consumer Defensive | $123.92B | 6.21% |
5SNOW | SNOWFLAKE INC | Technology | $93.20B | 4.67% |
6TTWO | TAKE TWO INTERACTIVE SOFTWARE INC | Communication Services | $43.94B | 2.20% |
7COIN | COINBASE GLOBAL INC | Financial Services | $41.40B | 2.07% |
8CBRE | CBRE GROUP INC | Real Estate | $41.28B | 2.07% |
9AXON | AXON ENTERPRISE INC | Industrials | $41.13B | 2.06% |
10CRWV | COREWEAVE INC | Technology | $39.94B | 2.00% |
11RVMD | REVOLUTION MEDICINES INC | Healthcare | $39.58B | 1.98% |
12WDAY | WORKDAY INC | Technology | $35.76B | 1.79% |
13EXPE | EXPEDIA GROUP INC | Industrials | $32.26B | 1.62% |
14DXCM | DEXCOM INC | Healthcare | $29.58B | 1.48% |
15JBHT | HUNT J B TRANSPORT SERVICES INC | Industrials | $27.48B | 1.38% |
16ECHO | ECHO GLOBAL LOGISTICS INC | Industrials | $26.66B | 1.34% |
17CPRT | COPART INC | Industrials | $25.56B | 1.28% |
18VRSN | VERISIGN INC | Technology | $25.27B | 1.27% |
19MDB | MONGODB INC | Technology | $25.12B | 1.26% |
20MRNA | MODERNA INC | Healthcare | $24.53B | 1.23% |
21CPAY | CORPAY INC | Technology | $23.91B | 1.20% |
22UTHR | UNITED THERAPEUTICS CORP | Healthcare | $22.74B | 1.14% |
23RIVN | RIVIAN AUTOMOTIVE INC | Consumer Cyclical | $22.00B | 1.10% |
24IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | Basic Materials | $19.96B | 1.00% |
25JLL | JONES LANG LASALLE INC | Real Estate | $15.34B | 0.77% |
26CRCL | CIRCLE INTERNET GROUP INC | Financial Services | $15.03B | 0.75% |
27BTSG | BRIGHTSPRING HEALTH SERVICES INC | Healthcare | $13.71B | 0.69% |
28KNX | KNIGHT-SWIFT TRANSPORTATION HOLDINGS INC | Industrials | $12.46B | 0.62% |
29BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | $11.52B | 0.58% |
30HUBS | HUBSPOT INC | Technology | $11.49B | 0.58% |
31HUT | HUT 8 CORP | Financial Services | $10.30B | 0.52% |
32CYTK | CYTOKINETICS INC | Healthcare | $9.98B | 0.50% |
33HALO | HALOZYME THERAPEUTICS INC | Healthcare | $9.23B | 0.46% |
34WULF | TERAWULF INC | Financial Services | $9.00B | 0.45% |
35OSCR | OSCAR HEALTH INC | Healthcare | $8.77B | 0.44% |
36ZG | ZILLOW GROUP INC | Communication Services | $7.71B | 0.39% |
37MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | $7.25B | 0.36% |
38CIFR | CIPHER DIGITAL INC | Financial Services | $7.18B | 0.36% |
39DBX | DROPBOX INC | Technology | $7.14B | 0.36% |
40HNGE | HINGE HEALTH INC | Healthcare | $6.74B | 0.34% |
41CORZ | CORE SCIENTIFIC INC | Technology | $6.66B | 0.33% |
42LUMN | LUMEN TECHNOLOGIES INC | Communication Services | $6.47B | 0.32% |
43SRRK | SCHOLAR ROCK HOLDING CORP | Healthcare | $6.33B | 0.32% |
44MYRG | MYR GROUP INC | Industrials | $6.10B | 0.31% |
45LYFT | LYFT INC | Technology | $5.89B | 0.30% |
46CAR | AVIS BUDGET GROUP INC | Industrials | $5.67B | 0.28% |
47ENPH | ENPHASE ENERGY INC | Technology | $5.48B | 0.27% |
48PEGA | PEGASYSTEMS INC | Technology | $5.39B | 0.27% |
49HRB | H&R BLOCK INC | Consumer Cyclical | $5.33B | 0.27% |
50TVTX | TRAVERE THERAPEUTICS INC | Healthcare | $5.27B | 0.26% |
51LAUR | LAUREATE EDUCATION INC | Consumer Defensive | $5.10B | 0.26% |
52DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | $4.83B | 0.24% |
53LBRDA | LIBERTY BROADBAND CORP | Communication Services | $4.43B | 0.22% |
54VKTX | VIKING THERAPEUTICS INC | Healthcare | $4.31B | 0.22% |
55ALHC | ALIGNMENT HEALTHCARE INC | Healthcare | $4.26B | 0.21% |
56ACLS | AXCELIS TECHNOLOGIES INC | Technology | $4.19B | 0.21% |
57MARA | MARA HOLDINGS INC | Financial Services | $4.08B | 0.20% |
58LION | LIONSGATE STUDIOS CORP | Communication Services | $4.03B | 0.20% |
59DOCS | DOXIMITY INC | Healthcare | $3.94B | 0.20% |
60TDS | TELEPHONE & DATA SYSTEMS INC | Communication Services | $3.90B | 0.20% |
61RLAY | RELAY THERAPEUTICS INC | Healthcare | $3.81B | 0.19% |
62PTEN | PATTERSON UTI ENERGY INC | Energy | $3.80B | 0.19% |
63DNLI | DENALI THERAPEUTICS INC | Healthcare | $3.70B | 0.19% |
64MSGE | MADISON SQUARE GARDEN ENTERTAINMENT CORP | Consumer Cyclical | $3.56B | 0.18% |
65CRGY | CRESCENT ENERGY CO | Energy | $3.55B | 0.18% |
66RNG | RINGCENTRAL INC | Technology | $3.46B | 0.17% |
67RCUS | ARCUS BIOSCIENCES INC | Healthcare | $3.44B | 0.17% |
68CLSK | CLEANSPARK INC | Financial Services | $3.34B | 0.17% |
69SEDG | SOLAREDGE TECHNOLOGIES INC | Technology | $3.25B | 0.16% |
70CWK | CUSHMAN & WAKEFIELD LTD | Real Estate | $3.20B | 0.16% |
71AD | ARRAY DIGITAL INFRASTRUCTURE INC | Communication Services | $3.02B | 0.15% |
72FRSH | FRESHWORKS INC | Technology | $3.01B | 0.15% |
73BRZE | BRAZE INC | Technology | $2.98B | 0.15% |
74RARE | ULTRAGENYX PHARMACEUTICAL INC | Healthcare | $2.88B | 0.14% |
75LCID | LUCID GROUP INC | Consumer Cyclical | $2.87B | 0.14% |
76SUPN | SUPERNUS PHARMACEUTICALS INC | Healthcare | $2.79B | 0.14% |
77CLDX | CELLDEX THERAPEUTICS INC | Healthcare | $2.77B | 0.14% |
78NMRK | NEWMARK GROUP INC | Real Estate | $2.77B | 0.14% |
79VERA | VERA THERAPEUTICS INC | Healthcare | $2.76B | 0.14% |
80NVTS | NAVITAS SEMICONDUCTOR CORP | Technology | $2.68B | 0.13% |
81KOD | KODIAK SCIENCES INC | Healthcare | $2.67B | 0.13% |
82TALO | TALOS ENERGY INC | Energy | $2.49B | 0.12% |
83BCRX | BIOCRYST PHARMACEUTICALS INC | Healthcare | $2.36B | 0.12% |
84AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | $2.36B | 0.12% |
85BHVN | BIOHAVEN LTD | Healthcare | $2.32B | 0.12% |
86NOG | NORTHERN OIL & GAS INC | Energy | $2.24B | 0.11% |
87IOVA | IOVANCE BIOTHERAPEUTICS INC | Healthcare | $2.23B | 0.11% |
88SION | SIONNA THERAPEUTICS INC | Healthcare | $2.23B | 0.11% |
89AGL | AGILON HEALTH INC | Healthcare | $2.17B | 0.11% |
90PPTA | PERPETUA RESOURCES CORP | Basic Materials | $2.11B | 0.11% |
91VERX | VERTEX INC | Technology | $2.07B | 0.10% |
92CDNA | CAREDX INC | Healthcare | $2.05B | 0.10% |
93SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | $2.02B | 0.10% |
94INOD | INNODATA INC | Technology | $1.99B | 0.10% |
95AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | $1.97B | 0.10% |
96NGL | NGL ENERGY PARTNERS LP | Energy | $1.89B | 0.09% |
97CPRI | CAPRI HOLDINGS LTD | Consumer Cyclical | $1.89B | 0.09% |
98SAM | BOSTON BEER CO INC | Consumer Defensive | $1.86B | 0.09% |
99MQ | MARQETA INC | Technology | $1.85B | 0.09% |
100NVCR | NOVOCURE LTD | Healthcare | $1.84B | 0.09% |
101LIND | LINDBLAD EXPEDITIONS HOLDINGS INC | Industrials | $1.81B | 0.09% |
102ASAN | ASANA INC | Technology | $1.77B | 0.09% |
103ZYME | ZYMEWORKS INC | Healthcare | $1.77B | 0.09% |
104AESI | ATLAS ENERGY SOLUTIONS INC | Energy | $1.76B | 0.09% |
105ANAB | ANAPTYSBIO INC | Healthcare | $1.69B | 0.08% |
106CMPS | COMPASS PATHWAYS PLC | Healthcare | $1.67B | 0.08% |
107TE | T1 ENERGY INC | Industrials | $1.63B | 0.08% |
108VIR | VIR BIOTECHNOLOGY INC | Healthcare | $1.59B | 0.08% |
109NTLA | INTELLIA THERAPEUTICS INC | Healthcare | $1.59B | 0.08% |
110BRUN | BOOST RUN INC | Technology | $1.50B | 0.08% |
111AHCO | ADAPTHEALTH CORP | Healthcare | $1.49B | 0.07% |
112TRS | TRIMAS CORP | Consumer Cyclical | $1.46B | 0.07% |
113MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | $1.45B | 0.07% |
114YELP | YELP INC | Communication Services | $1.44B | 0.07% |
115MRTN | MARTEN TRANSPORT LTD | Industrials | $1.44B | 0.07% |
116AIP | ARTERIS INC | Technology | $1.43B | 0.07% |
117CXM | SPRINKLR INC | Technology | $1.37B | 0.07% |
118AMN | AMN HEALTHCARE SERVICES INC | Healthcare | $1.36B | 0.07% |
119REAL | THEREALREAL INC | Consumer Cyclical | $1.35B | 0.07% |
120BW | BABCOCK & WILCOX ENTERPRISES INC | Industrials | $1.35B | 0.07% |
121DMLP | DORCHESTER MINERALS LP | Energy | $1.31B | 0.07% |
122FCEL | FUELCELL ENERGY INC | Industrials | $1.25B | 0.06% |
123CMP | COMPASS MINERALS INTERNATIONAL INC | Basic Materials | $1.24B | 0.06% |
124HTLD | HEARTLAND EXPRESS INC | Industrials | $1.19B | 0.06% |
125CVLG | COVENANT LOGISTICS GROUP INC | Industrials | $1.19B | 0.06% |
126MMI | MARCUS & MILLICHAP INC | Real Estate | $1.18B | 0.06% |
127MGTX | MEIRAGTX HOLDINGS PLC | Healthcare | $1.15B | 0.06% |
128EYPT | EYEPOINT INC | Healthcare | $1.12B | 0.06% |
129PCRX | PACIRA BIOSCIENCES INC | Healthcare | $1.01B | 0.05% |
130FBRX | FORTE BIOSCIENCES INC | Healthcare | $1.00B | 0.05% |
131EVC | ENTRAVISION COMMUNICATIONS CORP | Communication Services | $984M | 0.05% |
132KURA | KURA ONCOLOGY INC | Healthcare | $964M | 0.05% |
133ANNX | ANNEXON INC | Healthcare | $950M | 0.05% |
134GLIBA | GCI LIBERTY INC | Communication Services | $881M | 0.04% |
135REPL | REPLIMUNE GROUP INC | Healthcare | $859M | 0.04% |
136CYRX | CRYOPORT INC | Industrials | $832M | 0.04% |
137CODI | COMPASS DIVERSIFIED HOLDINGS | Industrials | $777M | 0.04% |
138REPX | RILEY EXPLORATION PERMIAN INC | Energy | $759M | 0.04% |
139IBTA | IBOTTA INC | Technology | $734M | 0.04% |
140AURA | AURA BIOSCIENCES INC | Healthcare | $723M | 0.04% |
141SXC | SUNCOKE ENERGY INC | Basic Materials | $710M | 0.04% |
142SPRY | ARS PHARMACEUTICALS INC | Healthcare | $695M | 0.03% |
143PKE | PARK AEROSPACE CORP | Industrials | $677M | 0.03% |
144SWBI | SMITH & WESSON BRANDS INC | Industrials | $665M | 0.03% |
145VTS | VITESSE ENERGY INC | Energy | $664M | 0.03% |
146ACHV | ACHIEVE LIFE SCIENCES INC | Healthcare | $644M | 0.03% |
147MEC | MAYVILLE ENGINEERING COMPANY INC | Industrials | $634M | 0.03% |
148RGR | STURM RUGER & CO INC | Industrials | $604M | 0.03% |
149PUBM | PUBMATIC INC | Technology | $591M | 0.03% |
150NGNE | NEUROGENE INC | Healthcare | $590M | 0.03% |
151ETD | ETHAN ALLEN INTERIORS INC | Consumer Cyclical | $580M | 0.03% |
152WEAV | WEAVE COMMUNICATIONS INC | Healthcare | $575M | 0.03% |
153EGY | VAALCO ENERGY INC | Energy | $553M | 0.03% |
154CTRN | CITI TRENDS INC | Consumer Cyclical | $535M | 0.03% |
155ARVN | ARVINAS INC | Healthcare | $517M | 0.03% |
156ADV | ADVANTAGE SOLUTIONS INC | Communication Services | $508M | 0.03% |
157OIS | OIL STATES INTERNATIONAL INC | Energy | $507M | 0.03% |
158TRC | TEJON RANCH CO | Industrials | $491M | 0.02% |
159SPIR | SPIRE GLOBAL INC | Industrials | $488M | 0.02% |
160PAYS | PAYSIGN INC | Technology | $478M | 0.02% |
161VMD | VIEMED HEALTHCARE INC | Healthcare | $466M | 0.02% |
162AMCX | AMC GLOBAL MEDIA INC | Communication Services | $461M | 0.02% |
163STRZ | STARZ ENTERTAINMENT CORP | Communication Services | $450M | 0.02% |
164SRTA | STRATA CRITICAL MEDICAL INC | Industrials | $446M | 0.02% |
165BOC | BOSTON OMAHA CORP | Communication Services | $430M | 0.02% |
166ASPN | ASPEN AEROGELS INC | Basic Materials | $425M | 0.02% |
167MCFT | MASTERCRAFT BOAT HOLDINGS INC | Consumer Cyclical | $407M | 0.02% |
168ENTA | ENANTA PHARMACEUTICALS INC | Healthcare | $400M | 0.02% |
169EBS | EMERGENT BIOSOLUTIONS INC | Healthcare | $394M | 0.02% |
170ABTC | AMERICAN BITCOIN CORP | Financial Services | $386M | 0.02% |
171UPB | UPSTREAM BIO INC | Healthcare | $382M | 0.02% |
172ULH | UNIVERSAL LOGISTICS HOLDINGS INC | Industrials | $377M | 0.02% |
173ZNTL | ZENTALIS PHARMACEUTICALS INC | Healthcare | $364M | 0.02% |
174MTRX | MATRIX SERVICE CO | Industrials | $342M | 0.02% |
175RTAC | RENATUS TACTICAL ACQUISITION CORP I | Industrials | $329M | 0.02% |
176VNDA | VANDA PHARMACEUTICALS INC | Healthcare | $327M | 0.02% |
177PAMT | PAMT CORP | Industrials | $311M | 0.02% |
178FHTX | FOGHORN THERAPEUTICS INC | Healthcare | $305M | 0.02% |
179ALCO | ALICO INC | Consumer Defensive | $304M | 0.02% |
180PNRG | PRIMEENERGY RESOURCES CORP | Energy | $302M | 0.02% |
181TKNO | ALPHA TEKNOVA INC | Healthcare | $291M | 0.01% |
182UCFI | CN HEALTHY FOOD TECH GROUP CORP | Consumer Defensive | $288M | 0.01% |
183TRDA | ENTRADA THERAPEUTICS INC | Healthcare | $268M | 0.01% |
184ALMU | AELUMA INC | Technology | $267M | 0.01% |
185SVCO | SILVACO GROUP INC | Technology | $260M | 0.01% |
186VNME | VENDOME ACQUISITION CORP I | Industrials | $254M | 0.01% |
187ARTV | ARTIVA BIOTHERAPEUTICS INC | Healthcare | $241M | 0.01% |
188GLSI | GREENWICH LIFESCIENCES INC | Healthcare | $240M | 0.01% |
189QUIK | QUICKLOGIC CORP | Technology | $237M | 0.01% |
190RMAX | RE/MAX HOLDINGS INC | Real Estate | $236M | 0.01% |
191GTE | GRAN TIERRA ENERGY INC | Energy | $233M | 0.01% |
192KPTI | KARYOPHARM THERAPEUTICS INC | Healthcare | $216M | 0.01% |
193PAL | PROFICIENT AUTO LOGISTICS INC | Industrials | $197M | 0.01% |
194COOK | TRAEGER INC | Consumer Cyclical | $193M | 0.01% |
195EAF | GRAFTECH INTERNATIONAL LTD | Industrials | $181M | 0.01% |
196KVHI | KVH INDUSTRIES INC | Technology | $178M | 0.01% |
197INSE | INSPIRED ENTERTAINMENT INC | Consumer Cyclical | $174M | 0.01% |
198AOUT | AMERICAN OUTDOOR BRANDS INC | Industrials | $174M | 0.01% |
199KORE | KORE GROUP HOLDINGS INC | Communication Services | $163M | 0.01% |
200RCEL | AVITA MEDICAL INC | Healthcare | $157M | 0.01% |
201HOFT | HOOKER FURNISHINGS CORP | Consumer Cyclical | $152M | 0.01% |
202ACNT | ASCENT INDUSTRIES CO | Basic Materials | $138M | 0.01% |
203DMRC | DIGIMARC CORP | Technology | $133M | 0.01% |
204BOOM | DMC GLOBAL INC | Energy | $128M | 0.01% |
205AARD | AARDVARK THERAPEUTICS INC | Healthcare | $128M | 0.01% |
206VATE | INNOVATE CORP | Industrials | $123M | 0.01% |
207INSG | INSEEGO CORP | Technology | $122M | 0.01% |
208TCX | TUCOWS INC | Technology | $114M | 0.01% |
209SSTI | SOUNDTHINKING INC | Technology | $111M | 0.01% |
210TRT | TRIO-TECH INTERNATIONAL | Technology | $103M | 0.01% |
211CHRN | CHRONOSCALE CORP | Industrials | $94M | 0.00% |
212GEOS | GEOSPACE TECHNOLOGIES CORP | Energy | $88M | 0.00% |
213RLYB | RALLYBIO CORP | Healthcare | $87M | 0.00% |
214AEYE | AUDIOEYE INC | Technology | $82M | 0.00% |
215PIII | P3 HEALTH PARTNERS INC | Healthcare | $78M | 0.00% |
216ACET | ADICET BIO INC | Healthcare | $76M | 0.00% |
217SCLX | SCILEX HOLDING CO | Healthcare | $72M | 0.00% |
218BGSF | BGSF INC | Industrials | $65M | 0.00% |
219EDSA | EDESA BIOTECH INC | Healthcare | $59M | 0.00% |
220SKIL | SKILLSOFT CORP | Consumer Defensive | $58M | 0.00% |
221LNZA | LANZATECH GLOBAL INC | Industrials | $56M | 0.00% |
222STEM | STEM INC | Technology | $56M | 0.00% |
223EXOZ | EXOZYMES INC | Healthcare | $51M | 0.00% |
Full long-leg book as of July 2026 · cap-weighted · total market cap $2.00T. Hypothetical model holdings — not a registered fund’s portfolio.
Sector Breakdown
Portfolio Style
Size × value map of the long-leg book
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 94% toward Large, 63% toward Growth. +12% unclassified (42 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → July 2026; the right-hand end is the same value as the box’s dot. 223 names now. Hypothetical holdings — descriptive, not P&L.
Constraint checks
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
Days required to liquidate the largest position at 20% of one day's dollar volume.
Required<= 7.0 daysActualunboundedMargin—
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700
Measured on the 2026-07 formation date across 223 holdings (cap-weighted). A different formation date can produce different verdicts.
Derivatives risk (Rule 18f-4)
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months
The estimators differ materially in value but agree on the verdict. Historical and Gaussian fund VaR differ by 20%; both still land on the same side of the 2x limit.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Since publication
Did the edge survive the paper coming out?
There is no “before” to compare against — the predictor was already public when our data begins, so every month shown is out-of-sample relative to the original study.
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Consistency across eras
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Returns
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 18.5% | 10.2% |
| 3 yearsp.a. | 24.6% | 0.2% |
| 5 yearsp.a. | 13.8% | 6.0% |
| 10 yearsp.a. | 17.8% | 7.4% |
| Since inceptionp.a. | 9.0% | -1.3% |
| Year | Long leg | Long-short |
|---|---|---|
| 20267 mo | 10.3% | 11.5% |
| 2025 | 24.1% | -11.3% |
| 2024 | 29.3% | -8.7% |
| 2023 | 62.0% | 43.4% |
| 2022 | -36.3% | 6.4% |
| 2021 | 36.4% | 13.1% |
| 2020 | 45.7% | 18.8% |
| 2019 | 21.0% | 6.8% |
| 2018 | -1.1% | 19.3% |
| 2017 | 7.9% | -22.5% |
| 2016 | 19.6% | 10.2% |
| 2015 | 15.1% | 16.4% |
| 2014 | 12.5% | -0.7% |
| 2013 | 42.6% | -0.6% |
| 2012 | 18.2% | 12.7% |
| 2011 | -0.8% | -5.0% |
| 2010 | 12.7% | -3.1% |
| 2009 | 52.2% | 18.0% |
| 2008 | -35.2% | -8.9% |
| 2007 | 12.6% | -14.6% |
| 2006 | 12.1% | 0.3% |
| 2005 | 2.0% | -14.4% |
| 2004 | 3.6% | -14.8% |
| 2003 | 55.4% | 21.0% |
| 2002 | -34.5% | -9.1% |
| 2001 | -18.9% | -13.6% |
| 2000 | -35.6% | -23.9% |
| 1999 | 13.6% | -40.5% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
Fund Facts
Methodology
The Foundry Earnings Quality (Accruals) Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a Earnings Quality (Accruals) signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Documents (draft — hypothetical)
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.